Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5983_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •About the Editor
- •Contents
- •Contributors
- •1.1.4 Components of niosome
- •1.1.5 Factors affecting niosomes
- •Preface
- •Abstract
- •1.1 Introduction
- •1.1.1 Why niosome?
- •1.1.2 Advantages of niosome
- •1.1.3 Structure of niosome
- •1.2 Applications of niosome
- •1.2.2 Niosomes for the delivery of therapeutics
- •1.2.3 Niosomes in biomedical applications
- •1.3 Conclusions and future prospects
- •Keywords
- •References
- •Abstract
- •2.1 Introduction
- •2.2 Conclusions
- •Acknowledgments
- •Keywords
- •References
- •Abstract
- •3.1 Introduction
- •3.2.1 Parameters involved in electrospinning process
- •3.2.2 Biomaterials for electrospinning
- •3.3 Electrospun nanofibers as drug delivery systems
- •3.3.1 Blending electrospinning
- •3.3.2 Emulsion electrospinning
- •3.3.3 Coaxial electrospinning
- •3.3.4 Surface modifications
- •3.4 Electrospun nanofibers for tissue engineering
- •3.4.1 Electrospun nanofibers for hard tissue engineering
- •3.5 Cancer diagnosis and therapy
- •3.6 Concluding remarks and future perspectives
- •Keywords
- •References
- •4. Natural Biocarriers for Brain Targeting
- •Abstract
- •4.1 Introduction
- •4.1.1 Central nervous system
- •4.2 Biocarriers
- •4.2.1 Carbohydrates carriers
- •4.2.2 Protein carriers
- •4.2.3 Exosomes
- •4.3 Conclusions and perspectives
- •Keywords
- •References
- •Abstract
- •5.1 Introduction
- •5.2 Synthesis of graphene family nanomaterials
- •5.2.1 Graphene synthesis
- •5.2.2 GO and rGO Syntheses
- •5.2.3 GQd synthesis
- •5.4 Drug delivery and biomedical applications
- •5.4.1 Drug delivery
- •5.4.2 Gene delivery
- •5.4.3 Bioimaging
- •5.4.4 Photothermal therapy
- •5.4.5 Tissue engineering
- •5.5 Summary and future prospect
- •Keywords
- •References
- •6. Nanotechnology in Gene Delivery
- •Abstract
- •6.1 Introduction
- •6.2 Gene delivery
- •6.3 Nanotechnology in gene delivery
- •Keywords
- •References
- •Abstract
- •7.1 Introduction
- •7.2 Additive manufacturing in pharmacology
- •7.2.1 Extrusion-based 3D printing techniques
- •7.2.2 Stereolithography
- •7.2.3 Selective laser sintering
- •7.2.4 Binder jet printing
- •7.3 Most common polymers
- •7.3.1 Natural polymers
- •7.3.2 Synthetic polymers
- •7.3.2.5 Polyvinylpyrrolidone
- •7.4 Common 3D-printed dosage forms
- •7.4.1 Scaffolds
- •7.4.2 Tablets
- •Keywords
- •References
- •7.4.3 Microneedles
- •7.4.4 Capsule
- •7.4.5 Films
- •7.5 Main factors in drug delivery
- •7.5.1 Nature of polymers
- •7.5.2 Matrix permeability
- •7.5.3 Polymer blends
- •7.5.4 Specific surface area
- •7.5.5 Infill density and patterns
- •7.5.6 Pores
- •7.5.7 Cross-linking
- •7.5.8 Coating
- •7.5.9 Core/shell and multicompartment
- •7.6 Final considerations and future perspectives
- •Abstract
- •8.1 Introduction
- •8.2.1 Polymer solution concentration and viscosity
- •8.2.2 Molecular weight of polymer
- •8.2.3 Surface tension
- •8.2.4 Electrical conductivity
- •8.2.5 Applied voltage
- •8.2.6 Feed rate/flow rate
- •8.2.7 Temperature and humidity
- •8.3 Method of preparation for nanofibers
- •8.3.1 Electrospinning
- •8.3.2 Self-assembly
- •8.3.3 Phase separation
- •8.3.4 Drawing of nanofibers
- •8.3.5 Template synthesis
- •8.4 Biomedical applications of nanofibers
- •8.4.1 Wound dressing
- •8.4.2 Tissue engineering
- •8.4.3 In cancer therapy
- •8.4.4 Miscellaneous
- •8.5 Drug delivery application
- •8.5.1 Antihypertensive drug
- •8.5.2 Antimicrobial drug
- •8.5.3 Growth hormone
- •8.5.4 Miscellaneous
- •8.6 Conclusion
- •Keywords
- •References
- •Abstract
- •9.1 Introduction
- •9.2 Tissue engineering
- •9.3 Nanotechnology
- •9.4 Polymeric scaffolds in tissue engineering
- •9.5 Challenges
- •Keywords
- •References
- •Abstract
- •10.1 Introduction
- •10.2 Ideal properties of bioceramics
- •10.2.1 Mechanical property
- •10.2.2 Porosity, pore size, and shape
- •10.2.3 Biocompatibility and biodegradability
- •10.2.4 Osteoconductivity and osseointegrity
- •10.3 Bioceramics in orthopedic applications
- •10.4 Bioceramics in maxillofacial surgery
- •10.5 Bioceramic in drug delivery applications
- •10.6 Doped bioceramic in biomedical application
- •10.7 Conclusions
- •10.8 Future direction
- •Acknowledgments
- •Keywords
- •References
- •Index

248
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
8.2.1 POLYMER SOLUTION CONCENTRATION AND VISCOSITY
-
tration plays an important role. Whereas the viscosity also plays a great
8.2.2 MOLECULAR WEIGHT OF POLYMER
-
tion (Haghi and Akbari, 2007).
8.2.3 SURFACE TENSION
8.2.4 ELECTRICAL CONDUCTIVITY

Nanofiber Technology in Biomedical Applications
249
Mit-uppatham et al., 2004).
8.2.5 APPLIED VOLTAGE
8.2.6 FEED RATE/FLOW RATE
8.2.7 TEMPERATURE AND HUMIDITY
al., 2013).

250
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
8.3 METHOD OF PREPARATION FOR NANOFIBERS
8.3.1 ELECTROSPINNING
-
al., 2009).
8.3.2 SELF-ASSEMBLY

Nanofiber Technology in Biomedical Applications
251
-
amine and its deacetylated derivative. Here the individual components
ranging in nanometers than the electrospinning technique (Jayaraman et
et al., 2003).
8.3.3 PHASE SEPARATION
-
FIGURE 8.1

252
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
-
Ramakrishna, 2005).
FIGURE 8.2
8.3.4 DRAWING OF NANOFIBERS
-
et al., 2011).

Nanofiber Technology in Biomedical Applications
253
FIGURE 8.3
8.3.5 TEMPLATE SYNTHESIS
structure. Generally nanoporous metal oxide membranes such as aluminum
8.4 BIOMEDICAL APPLICATIONS OF NANOFIBERS

254
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
TABLE 8.1
Biomedical
application
System name Drug used Polymer used References
Wound
dressing
Electrospun
Cloxacillin PLA and poly(butylene
adipate-co-terephthalate)
Schneider et
al., 2018
Electrospun
acetate
CS and PVA Abbaspour
et al., 2015
engineering
Electrospun
polymeric
NA Cellulose acetate and
iron acetate
Mousa et al.,
2021
Electrospun
NA PCL and CS Semnani et
al., 2017
Cancer
therapy
Electrospun
5-Fluorouracil PCL and CS
al., 2018
Electrospun
Paclitaxel PLGA and CS
2020
FIGURE 8.4

Nanofiber Technology in Biomedical Applications
255
8.4.1 WOUND DRESSING
-
have been introduced incorporating various antibiotics that are required
-
Staphylococcus aureus
concluded that the prepared cloxacillin-loaded biocompatible electrospun

256
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
enhanced antimicrobial activity against Pseudomonas aeruginosa and S.
aureus
al., 2015).
8.4.2 TISSUE ENGINEERING
skin, bone, dentin, collagen, and liver. Both natural and synthetic
possess the ability to repair, replace, and regenerate the required tissues,
nature, high quality mechanical properties, high porosity, ability to
osteoblastic adhesion, and extracellular matrix secretion on the carbon
-
-
(Eatemadi et al., 2016).

Nanofiber Technology in Biomedical Applications
257
-
(Mousa et al., 2021).
-
-
the cells (Semnani et al., 2017).
8.4.3 IN CANCER THERAPY
healthy tissue, and a high removal rate by the reticuloendothelial system.
has the potential to rule out the various disadvantages and it also can be
-
drugs such as dichloroacetate, cisplatin, paclitaxel, and doxorubicin can
Соседние файлы в папке Библиотека им академика М.И. Перельмана
